Catalyst Wire Dossier Catalyst Wire Dossier

CIMDUO

LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE · Viatris Specialty LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CIMDUO, covering 2018-02-28 to 2018-07-10. Get the full timeline:

Most recent: FDA Approved: CIMDUO — Supplemental Application (Viatris Specialty LLC)

See pricing